Good vision outcomes are seen with immunomodulators for sympathetic ophthalmia

• Posted on: Dec 4 2023
• By: Saratoga Opthalmology
• Leave a response

Less vision loss due to inflammation associated with sympathetic ophthalmia was seen following long-term treatment with immunomodulatory therapy (IMT), particularly alkylating agents, than with corticosteroid therapy.
Source: AAO

Posted in: Uncategorized